Any findings that MS patients have Chlamydia infections significantly more frequently than healthy individuals??? It is a very compelling story, but nothing substantiate it.
This is disingenuous. Look to Wheldon's website and the citations he provides. Print out the FULL articles and read them back to front, multiple times. Wheldon points to three pivotal studies: Sriram , Buljevac  & Munger  that pin down an association between MS and C. pneumoniae
; not mentioning the countless other studies that give merit to this idea, as well, which Wheldon plainly cites on his website.
if these studies are so compelling, why is it not an accepted therapy for MS? What do these studies show? So, all the scientists , neuros are stupid or they just did not have the time in the last twenty years to read these compeling studies.
Then, tell me what test should I get to determine whether my MS is caused by Cpn!!! It is really sad that it has been more than 20 years that nothing has been proved. The fact that Vanderbilt guys are not confident about their CAP and that they could not complete any trials tells a lot.
I take it that you mean "HSCT" as non-myeloablative implantation of stem cells. Unfortunately, an "ongoing trial" can verify nothing. Only until the data is totally compiled and analyzed, from a completed trial, can you begin to draw inferences. And these inferences slowly lose credibility the shorter the observational period post-experimental treatment (Heaven have mercy on those trials without an observational period). Interferons and glatiramer acetate show some viability, but in the long term? Neutralizing antibodies to interferon; glatiramer acetate does not stop progression to progressive form.
HSCT is applied for many years off-label and you can find many people even here in tims who went through it and symptom free. Not only one Sarah, but many.
At least there are ongoing trils for HSCT, but show me one for CAP!!!! Only anecdotes....HSCT is also accepted by neuros as it fits what we know about MS.
Antibiotics have been prescribed for timelines, similar to what Wheldon proposes, for other disease indications, and is a much smaller ball of wax than HSCT, let alone much less costly. The fact that Sarah's disease progression was halted, for such a long period of time [going on towards a decade now], at a time when her disease state was diagnosed as progressive, should speak volumes in and of itself.
You said it, it is much less costly. So, what holds you back to have a clinical trial completed? There are diets, food supplements currently on trial. ...Again, only Sarah...That is only one case. Search the web and you will find many such cases for different "cures".
From one of the published articles by Stratton and Wheldon, it appeared as if Wheldon had plans of observing his cases (i.e., patients he has treated) in the long-term before attempting to publish any of his findings in an academic journal. I hope this is true, however, it does not mean that it will happen. Wheldon is retired and he is only getting older. Sarah is getting older, too. Nevertheless, even if Wheldon did so, I imagine it would be criticized for not being double-blinded or placebo-controlled, or TOO homogenous even!
Curious Robot, believe me, I would be happy if such study would appear somewhere. We should clarify how to identify whose MS is caused by Cpn and which protocol is effective as a treatment. So far, there is nothing.